⚖️DEA Revokes Registration of Texas Doctor for Non-Compliance
The Drug Enforcement Administration has revoked the medical license of Dr. Andrew Konen, citing non-compliance with regulations concerning the prescription of controlled substances. The decision follows findings of numerous violations related to the issuance of prescriptions lacking legitimate medical purpose and inadequate patient evaluations, underscoring the critical importance of strict adherence to regulatory standards in medical practice.
Learn More⚖️Extension of Temporary Scheduling for Designer Benzodiazepines
The Acting Administrator of the Drug Enforcement Administration (DEA) is issuing this temporary scheduling order to extend the temporary schedule I status of five designer benzodiazepines--clonazolam, diclazepam, etizolam, flualprazolam, and flubromazolam. In an order dated July 26, 2023, DEA temporarily placed these five substances in schedule I of the Controlled Substances Act. This temporary order will extend the temporary scheduling of five designer benzodiazepines for one year, or until the permanent scheduling action for these substances is completed, whichever occurs first. As a result of this order, the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances will continue to be imposed on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle these five specified controlled substances.
Learn More⚖️DEA Revocation
The Drug Enforcement Administration revokes the registration of Sasha Melissa Ikramelahai due to allegations of material falsification and lack of state authority to handle controlled substances in North Carolina. The case underscores the significance of regulatory compliance in the healthcare sector, emphasizing the severe consequences businesses face when failing to uphold licensure integrity.
Learn More⚖️DEA Suspension of Registrant
The Drug Enforcement Administration's recent order revokes Scott Hansen's registration due to allegations of improper prescribing while his nursing license was suspended. The case highlights critical compliance issues regarding the authority of healthcare practitioners to prescribe controlled substances, emphasizing the importance of adherence to both federal and state regulations.
Learn More📦Patheon API Inc. Applies for Controlled Substances Import Registration
Patheon API Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More⚖️Implications of DEA Registration Revocation for Medical Practitioners
The Drug Enforcement Administration (DEA) issued an order revoking the registration of Syed Warsi, M.D., due to the suspension of his medical license in Illinois. This decision, based on the authority of federal and state laws, emphasizes the critical need for practitioners to maintain valid licenses to handle controlled substances, impacting compliance within the healthcare sector.
Learn More⚖️DEA Revokes Registration of David Israel, M.D. for Misconduct
The Drug Enforcement Administration issued an order revoking David Israel, M.D.’s DEA registration due to unlawful prescription practices outside the usual course of professional practice. Allegations include issuing prescriptions for controlled substances without legitimate medical purpose, leading to significant legal and operational implications for the medical professional.
Learn More⚖️Revocation of Medical Registration
The Drug Enforcement Administration issued an Order to Show Cause for the revocation of Dr. Henry-Norbert O. Ndekwe's registration due to his lack of authority to handle controlled substances in Oklahoma. The document outlines the legal processes regarding the revocation and highlights the implications for healthcare practitioners and businesses in the industry.
Learn More⚖️DEA Revokes Registration of Texas Practitioner
The Drug Enforcement Administration has revoked the DEA registration of Willard J. Davis, D.O., due to his lack of authority to handle controlled substances in Texas following the suspension of his medical license. The decision emphasizes the need for practitioners to possess valid licenses to maintain DEA registration.
Learn More⚖️DEA Revokes Registration of Hazem Barmada, M.D. for Compliance Issues
The Drug Enforcement Administration has revoked Hazem Barmada, M.D.'s certification due to his lack of licensure in Mississippi, impacting his ability to handle controlled substances. This decision underscores the necessity for medical practitioners to maintain state compliance to retain DEA registrations and operate legally.
Learn More